Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wakamoto Pharmaceutical CoTSE:4512 63 Dividend Payout Ratio is 0.34 as of Mar. 2026, which is 62% below its 10-year median of 0.89. GuruFocus rates TSE:4512 with a GF Score™ of 63/100 and a GF Value™ of 円319.10 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 445 Drug Manufacturers companies, Wakamoto Pharmaceutical Co ranks worse than 69.21% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Wakamoto Pharmaceutical Co's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.34.
The historical rank and industry rank for Wakamoto Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:
TSE:4512'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.53 Med: 0.89 Max: 2.03
Current: 0.53
During the past 13 years, the highest Dividend Payout Ratio of Wakamoto Pharmaceutical Co was 2.03. The lowest was 0.53. And the median was 0.89.
TSE:4512's Dividend Payout Ratio is ranked worse than 69.21% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs TSE:4512: 0.53
During the past 13 years, the highest Trailing Annual Dividend Yield of Wakamoto Pharmaceutical Co was 1.57%. The lowest was 0.84%. And the median was 1.10%.
During the past 12 months, Wakamoto Pharmaceutical Co's average Dividends Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Wakamoto Pharmaceutical Co was 5.30% per year. The lowest was 0.00% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Wakamoto Pharmaceutical Co (TSE:4512) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Wakamoto Pharmaceutical Co Dividend Payout Ratio Related Terms
Wakamoto Pharmaceutical Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wakamoto Pharmaceutical Co Dividend Payout Ratio Chart
TSE:4512 vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Wakamoto Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wakamoto Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Wakamoto Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Wakamoto Pharmaceutical Co's Dividend Payout Ratio falls into.
Wakamoto Pharmaceutical Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Wakamoto Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wakamoto Pharmaceutical Co (TSE:4512) has a Dividend Payout Ratio of 0.34 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Wakamoto Pharmaceutical Co and its competitors. This is 62% below median its historical median of 0.89. Over the past decade, Wakamoto Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.53 to 2.03. According to the industry distribution chart, Wakamoto Pharmaceutical Co ranks #308 out of 445 companies in the Drug Manufacturers industry, placing it in the top 69.2%.
Is Wakamoto Pharmaceutical Co's Dividend Payout Ratio too high?
Wakamoto Pharmaceutical Co's current Dividend Payout Ratio of 0.34 is 62% below median its 10-year median of 0.89. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 2.03. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Wakamoto Pharmaceutical Co's value of 0.34 is 10.5% below this industry median. Based on the distribution chart, Wakamoto Pharmaceutical Co ranks #308 out of 445 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Wakamoto Pharmaceutical Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wakamoto Pharmaceutical Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Wakamoto Pharmaceutical Co ranks #308 out of 445 companies for Dividend Payout Ratio. This places Wakamoto Pharmaceutical Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Wakamoto Pharmaceutical Co's value of 0.34 is 10.5% below this benchmark. Historically, Wakamoto Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.53 to 2.03 over the past decade. While the company's 10-year median is 0.89 vs. the industry median of 0.38, Wakamoto Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wakamoto Pharmaceutical Co's current Dividend Payout Ratio of 0.34 is 10.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Wakamoto Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wakamoto Pharmaceutical Co's current Dividend Payout Ratio is 0.34, which is 62% below median its own 10-year median of 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wakamoto Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Wakamoto Pharmaceutical Co (TSE:4512) is currently considered Modestly Undervalued. The stock's GF Value™ is 円319.10, compared to a current price of 円278.00 — trading 12.9% below its estimated fair value. The current Dividend Payout Ratio is 0.34, which is 62% below median its 10-year median of 0.89 and 10.5% below the Drug Manufacturers industry median of 0.38. Wakamoto Pharmaceutical Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Wakamoto Pharmaceutical Co (TSE:4512), the current Dividend Payout Ratio is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wakamoto Pharmaceutical Co (TSE:4512) Overvalued in 2026?
Based on GuruFocus' analysis, Wakamoto Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円278.00 is trading 12.9% below its estimated GF Value™ of 円319.10.
GuruFocus considers Wakamoto Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TSE:4512:
Dividend Payout Ratio: 0.34 (62% below median its 10-year median of 0.89)
GF Value™: 円319.10 vs. price of 円278.00 (12.9% below fair value)
Industry Position: 10.5% below the Drug Manufacturers median (#308 of 445)
No single metric tells the full story. See the TSE:4512 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.
63GF Score
Get the complete analysis for TSE:4512
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4512 has been successfully added to your 
